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Abstract Leprosy can manifest arthritis both as a complica-
tion and a comorbid disorder and can be a challenging differ-
ential diagnosis in rheumatology practice due to several
common features. Uncommonly, it may present as acute se-
vere polyarthritis with skin lesions and neurological deficit or
a digital vasculitis and gangrene. We demonstrate this profile
in a retrospective case series analysis of 33 patients (13
females, median age 55 years) in a community-based clinic
setting over the period 1998–2012; an electronic search of
case records of 41,000 patients was carried out. Rheumatoid
arthritis (RA) coexisted in seven patients (three lepromatous,
two tuberculoid, and two polyneuritic). Serological rheuma-
toid factor and antinuclear antibody were often false positive.
Several patients of RAwere on long-term supervised metho-
trexate. Rheumatologists should be aware of this clinical
mimic to avoid errors in diagnosis and management.
Keywords Arthritis . Hansen’s disease . Infection .
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Introduction
Leprosy is an ancient infectious disease that is only known
to afflict human beings and continues to be an important
prevalent disease in several developing nations. The global
registered prevalence of leprosy at the beginning of 2012
stood at 181,941 cases [1].
Though routinely seen by dermatologists, leprosy is
reported to present uncommonly in rheumatology practice
as primary arthritis or a coexistent infection or a complica-
tion of therapy. Rheumatologists should be aware of this
disease since some form of joint involvement is reported to
occur in 75 % of cases of leprosy and at times may be the
only obvious manifestation [2].
Joint pain and arthritis are usually seen during the reac-
tive inflammatory phase. In addition, Hansen’s disease may
uncommonly cause a chronic erosive deforming arthritis,
involving both large and small joints, which resembles
rheumatoid arthritis [3]. It is also known to present with
clinical and laboratorial findings that mimic autoimmune
connective tissue diseases and vasculitis [4].
In another rare parallel, leprosy has been reported in
patients with human immunodeficiency virus (HIV) infec-
tion on antiretroviral therapy, as a manifestation of immune
reconstitution inflammatory syndrome [5].
We present a retrospective analysis of a case series of 33
patients examined and diagnosed as Hansen’s disease. The
aim was to describe the clinical profile relevant to rheuma-
tology practice and highlight the error of a misdiagnosis. A
brief review of literature is also presented.
Materials and methods
The present study was carried out in the Center for
Rheumatic Disease (CRD), Camp, Pune, which is a private
community-based referral facility in the state of Maharashtra
(www.rheumatologyindia.org). CRD has carried out several
community arthritis camps and population surveys [6, 7] in
the region and is a recognized research institute with facil-
ities for post-masters doctorate program (PhD). We examine
about 85–100 patients daily.
We retrospectively carried out a cross-sectional electronic
search of case records in the referral database of CRD
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between 1998 and 2012 and retrieved case records of pa-
tients who had been diagnosed with leprosy and or leprosy–
arthritis during examination in the center (other search
words included Hansen’s arthritis and lepra reaction).
Forty-one thousand case records were screened.
Every patient was examined by a rheumatologist, and
findings are recorded in a standard case record form
(CRF). The CRF includes a 68/66 joint count chart for
pain/tenderness and swelling (as recommended by the
American College of Rheumatology), pain visual analog
scale (VAS), global assessment, health assessment question-
naire, and detailed systemic evaluation. All patients were
also examined by a dermatologist (EC). Some patients were
referred to a neurophysician and, if required, evaluated with
a nerve conduction study. The diagnosis of Hansen’s disease
was essentially clinical and supported by a demonstration of
acid-fast bacilli (AFB) in skin biopsy.
Diagnostic work-up included complete hemogram, rou-
tine urine analysis, metabolic hepatic renal and lipid profile,
and serological markers like rheumatoid factor (RF) and C-
reactive protein (CRP) by nephelometry. Skin testing/biopsy
was often performed by the dermatologist. Slit-skin smear
from the ear lobe was obtained and examined for AFB by
Ziehl–Neelsen staining method, and the bacteriological and
morphological indices were evaluated by the dermatologist.
Sural nerve biopsy was carried out in few cases. A summary
of the clinical profile of three patients with challenging
clinical scenarios is also presented.
Results
Thirty-three patients (20 males, median age 55 years) were
identified. All the cases had follow-up records for at least 6
months. None of the patients had a positive family history of
leprosy, and all belonged to middle socioeconomic status with
an almost equal divide between urban and rural regions.
Inflammatory arthritis was diagnosed in 28 patients (7
rheumatoid arthritis (RA) and 21 undifferentiated), nonspecific
arthritis in 5 patients, and vasculitis in 1 patient. Twenty-two,
nine, and two patients, respectively, were classified as
lepromatous leprosy (LL), tuberculoid leprosy (TT), and
polyneuritic leprosy. Table 1 describes the demographic and
other selected relevant features.
Leprosy was detected in 19 patients who had presented
earlier with primary inflammatory arthritis (often RA-like);
in five patients (three women), the flare in arthritis was
associated with features of type I reaction. On careful as-
sessment, at least 20 cases had been suspected/diagnosed of
leprosy prior to developing chronic arthritis. An almost
simultaneous onset of arthritis and detection of leprosy
was observed in 13 patients. There was a male preponder-
ance (Table 1) in the study. RA coexisted in seven patients
(three in LL and two each neuritic and TT), and it preceded
Hansen’s disease in three cases. The patients had symmet-
rical polyarthritis. Articular deformities akin to RA were
seen in 12 patients; in five patients, it was “claw hand”
(Fig. 1) rather than actual articular deformity. At least three
patients with obvious finger flexion deformities and inabil-
ity to make a fist did not show any radiological abnormality
typical of RA.
Two patients showed features of digital vasculitis with
symptomatic oral sicca. None of the patients showed fea-
tures of enthesitis. On close examination, the skin lesions
were often characteristic of Hansen’s disease. Twenty-two
patients had clinical peripheral neuropathy (Table 2) with
Table 1 Rheumatoid arthritis (RA) and undifferentiated inflammatory
arthritis (IA-U) (percentage frequency)
Features RA (n = 7) IA-U (n = 21)
Male 71 57
Female 29 43
Median age years (range) 55 (29–60) 48(20–72)




after onset of Hansen’s disease
43 62
Patients developing Hansen’s
disease after onset of arthritis
57 19
Patients developing Hansen’s
disease and arthritis simultaneously
0 19
Lepromatous leprosy 42 76
Neuritic 29 0






Type II reactions 15 29
Type I (upgrading) 0 10
Type I (downgrading) 15 10
Fig. 1 Patient showing claw hand in both the hands
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predominant glove and stock-type pattern of sensory loss;
pure sensory loss was found in 13 patients. Five patients
(three lepromatous) had feet digital trophic ulcers in addi-
tion to neuropathy. Nerve conduction velocity (NCV) was
required to confirm the typical axonal type neuropathy in
four patients (two tuberculoid, one lepromatous, and one
neuritic leprosy).
Fifteen patients (13 on anti-Hansen’s disease drugs) were
seen in reactional states [type I downgrading/upgrading and
type II (erythema nodosum leprosum, ENL)] (Table 1).
Sixty percent of the reactions in the study were type II,
encountered in patients of lepromatous leprosy. At least four
patients of tuberculoid leprosy with inflammatory arthritis
and on antiarthritis therapy suffered from downgrading re-
action and moved towards the lepromatous profile. Patients
in the reactional state were usually found to look sick with
puffiness on the face, hands, and feet and mild edema; often,
skin lesions looked exaggerated, and some even showed
small irregular ulcers over the hands and feet. One patient
presented with a tender hepatomegaly.
Methotrexate was used to control severe RA. However,
two patients on long-term methotrexate developed Hansen’s
skin lesions (Fig. 3). In 57 % of cases (88 % lepromatous),
the skin clipping was shown to be positive for AFB stain;
AFB status could not be confirmed in eight patients with
history of leprosy in the past. We carried out full thickness
skin biopsy/histopathology study in two patients (one each
lepromatous and tuberculoid) to confirm the diagnosis.
Other rheumatology work-up showed that in patients with
inflammatory arthritis and leprosy, 26.6 % were seropositive
for RF and 37.5 % were seropositive for ANA. Several
patients were tested for HIV, serological tests for syphilis,
and other autoantibodies performed in rheumatology prac-
tice (including anticyclic citrullinated peptide/anti-CCP and
found seronegative).
Case 1 A 33-year-old nonsmoker male, a known case of
Hansen’s disease (skin biopsy-proven borderline leproma-
tous) on supervised long-term treatment (prednisolone and
clofazimine) since 4 years was referred to the rheumatology
clinic with an acute onset of feeling cold in the index,
middle, and ring finger of the left hand; since 1 month, he
recalled episodic severe pain and burning sensation in the
fingers. The patient did not have diabetes or any other
relevant disease. Ten days later, he developed painful gan-
grene of the digital pulps of the index, middle, and ring
finger of the left hand (Fig. 2).
On examination, he also had atrophied, nodular, and healed
ulcerative scars over the face, neck, and extremities with few
scattered diffuse hypopigmented hypoesthetic lesions; ulnar
and peroneal nerves were thickened. New skin lesions or any
other systemic abnormality was absent. Detailed laboratory
investigations showed normal erythrocyte sedimentation rate
(ESR) with mild normocytic normochromic anemia, margin-
ally raised C-reactive protein; seronegativity for RF, ANA,
anti-CCP, and anticardiolipin antibodies; and seropositivity
for isolated anti-ds DNA (ELISA) in low titer. Routine cardiac
evaluation (including Doppler/echo) was normal, and periph-
eral blood flow Doppler studies suggested reduced distal
arterial blood flow in the right arm. A right subclavian artery
angiography was consistent with focal distal arteritis lesions.
Other causes like cervical rib and proximal subclavian/arterial
compressive lesions were excluded. A diagnosis of vasculitis
was made and considered to be a likely complication of
leprosy. A short course of tapering high dose of orally admin-
istered prednisolone (begun at 30 mg daily and 6 weeks later
Table 2 Neurological manifes-
tations (n = 21) with lepra reac-
tions (n = 15)






Dominant sensory 5 8 0
Dominant sensory motor 1 5 2
Thickened nerve 4 3 0
Claw hand/feet deformity 1 1 2
Trophic ulcers 2 3 0
Diagnostic NCV 1 1 2
Lepra reaction type I (downgrading) 2 3 0
Lepra reaction type II 0 4 0
Fig. 2 Case 1 showing digital pulp gangrene in the left hand
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on 5 mg daily), orally administered hydroxychloroquine, and
antiplatelet agents was added to ongoing anti-leprosy drugs.
The patient showed steady recovery, and the affected digital
pulps healed with scars and some loss of pulp substance.
Case 2A 55-year-old male patient with chronic RA of 9 years
in duration was well controlled (near remission) with long-
term supervised administration of leflunomide and methotrex-
ate. The patient developed acute urticaria-like rash on the
neck, and upon consultation with the dermatologist, oral
hydroxychloroquine and a short course of oral prednisolone
were added. After a modest response, the patient developed
erythematous papulonodular nontender itchy lesions (Fig. 3)
all over the body, but maximally over the lower trunk and
abdomen along with polyarthralgias and severe painful right
ankle swelling and a limping gait. The patient was afebrile and
did not have any other systemic abnormality. Leflunomide
was suspected to have caused the skin lesions and was
stopped. Serum uric acid level was significantly elevated
and allopurinol, prescribed. Orally given diclofenac was
added for the symptomatic relief of arthritis but was
discontinued (? hypersensitivity) because the skin lesions
worsened (relapse of generalized urticaria lesions). The skin
lesions were opined to be a drug-induced leucocytoclastic
reaction/vasculitis; allopurinol was also stopped. A moderate-
ly high dose of orally given methyl prednisolone with a slow
taper (over weeks) was started. A concurrent work-up was
negative for ANA and other collagen vascular diseases. A
week later, the patient had made little recovery, and a skin
biopsy was carried out which demonstrated AFB and a histo-
pathological picture consistent with a lepromatous reaction.
The patient was started on multidrug treatment (dapsone,
rifampicin, clofazimine), and the patient responded clinically
(bearable pain and mild limping) over 12 weeks or so. Oral
weekly administration of 15 mg methotrexate, along with
daily administration of 400 mg hydroxychloroquine and
low-dose steroids (7.5–10 mg prednisolone), was continued.
Moderate to severe polyarthritis continued, with elevated
ESR, and hence, 2 g sulfasalazine and 100 mg minocycline
were added. Few days later, the patient developed severe oral
aphthous ulcers, requiring stoppage of methotrexate. The
arthritis and skin lesions settled over almost 15 months of
intense follow up. After a period of waxing and waning, the
skin lesions of Hansen’s disease also subsided with diffusely
scattered reddish brown macules.
Case 3 A 52-year-old woman presented with painful rapidly
progressive symmetrical polyarthritis of about 4 months in
duration, without any extra-articular features, and was diag-
nosed with clinical RA. She was grossly limited in her daily
activities and complained of prolonged morning stiffness.
Other than symptomatic treatment, she also begun on oral daily
administration of 10 mg leflunomide and 5 mg prednisolone.
She was also on regular supervised medication for diabetes,
hypertension, and epilepsy. On questioning, she recalled a
history suggestive of suffering from leprosy (?polyneuritic)
along with pulmonary tuberculosis several years ago and re-
ceiving prolonged therapy for about 18 months.
Two months later, she developed erythematous scaly mac-
ular rash on the back and lower limbs along with small ulcers
on both soles. The arthritis was almost settled, and minimal
tenderness elicited in the wrists and small joints of the hands.
Her ankles and feet looked somewhat puffy. She complained of
numbness and abnormal feeling in the feet and lower part of the
legs. Neurological examination showed wasting of thigh mus-
cles and hyperesthesia in the upper and lower limbs. She did
not have any other systemic abnormality. Laboratory investi-
gations showed a near normal hemogram with elevated CRP
and seronegative for RF, ANA, and anti-CCP. Metabolic and
hepatic parameters were normal, but renal functions were mild-
ly derangedwith elevated serum creatinine. Her serum uric acid
was grossly elevated at 12.0 mg/dl (lab normal <7 mg/dl). X-
ray of the hands showed juxta-articular osteoporosis and ero-
sions typical of RA. Ultrasonography of the abdomen and
pelvis showed mild hepatomegaly only. She was further inves-
tigated by a dermatologist who opined that the current compli-
cation was an activation of old leprosy in the form of probable
lepra reaction, but a close differential of an adverse event due to
leflunomide was also considered; skin clip was negative for
AFB. The antiarthritis medication was changed to only symp-
tomatic drugs, and anti-leprosy drugs were added and contin-
ued with low-dose orally given prednisolone. Six months later,
she improved considerably with healed skin lesion, minimal
numbness in the extremities, and absence of arthritis.
Discussion
Hansen’s disease [8] continues to manifest protean clinical
features that include rheumatic musculoskeletal disorders as
demonstrated in this report. A 1–5 % of leprosy patients are
Fig. 3 Case 2 showing erythematous papulonodular itchy skin lesions
on the abdomen and lower trunk
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reported to develop arthritis of the small joints of the hands
and feet akin to that seen in rheumatoid arthritis [9, 10].
Considering that Hansen’s disease is not an uncommon
disorder in India and only 33 patients of leprosy with arthri-
tis were encountered over a 20-year period in a busy rheu-
matology clinic (current report) suggests a much lower
prevalence of this complication. However, cases of leprosy
are predominantly managed in dermatology outpatient of
government-run general hospitals and primary health cen-
ters (rural) in our setting and are generally not referred to the
rheumatologist. In this report, we also show that patients of
chronic RA on long-term immunosuppression can develop
leprosy, requiring a high index of clinical suspicion for
timely diagnosis.
We encountered leprosy reactions in several of our pa-
tients (Table 1). In the current report, 15 patients were seen
in reactional states and were divided between all the three
types of lepra reaction causing diagnostic confusion. Sixty
percent of the reactions in the study were type II, encoun-
tered in patients of lepromatous leprosy. At least four pa-
tients of tuberculoid leprosy with inflammatory arthritis
suffered from downgrading reaction and moved towards
the lepromatous profile. The expression of the reactions
was largely edematous and seen on the face and lower limbs
(puffy feet and ankles).
Patients with leprosy can present with two types of
immune-mediated lepra reactions which are characteristic
and need early detection and management [11] to avoid con-
siderable morbidity (and rarely mortality). Type I reaction is a
class IV hypersensitivity reaction with heightened cell-
mediated immunity and seen in borderline forms (not polar)
of leprosy. When occurring prior to therapy, the patient
worsens (downgrading) and develops features of lepromatous
leprosy: fever, edema, inflammatory skin lesions, and severe
painful neuritis (manifesting as tender peripheral nerves, foot
drop, claw hand, and facial palsy). Sometimes, type 1 reaction
(reversal) is seen after the therapy is begun, and the clinical
expression may progress toward the tuberculoid end. Type II
is a class III hypersensitivity reaction occurring during the
course of the treatment of patients with lepromatous forms
(borderline/BL and polar lepromatous /LL). Also called ery-
thema nodosum leprosum (ENL), the patient may develop
severe immune complex-driven multisystemic features.
Histologically, it appears to be a polymorph nuclear vasculitis
or panniculitis. Although ENL is characterized by a TH2
cytokine profile with a high interleukin 6 and 8 assay [12], it
may exhibit unusually high levels of tumor necrosis factor and
IL-2. It is an immune complex deposition disorder. ENL is
characterized by a sudden appearance of crops of evanescent
erythematous tender nodules, whichmay become pustular and
ulcerate. Patients are often febrile with features of neuritis,
lymphadenitis, orchitis, and arthritis (often seen in knees and
other large joints) and glomerulonephritis. Besides arthritis,
ENL has been associated with necrotizing cutaneous vasculi-
tis, septic arthritis, neuropathic arthritis, and swollen hand
syndrome. Further, anemia may be caused due to red blood
cell destruction or bone marrow suppression.
The multisystemic nature of leprosy, especially in a setting
of a lepra reaction, may mimic septicemia. Finally, just like
syphilis, Hansen’s disease is a great mimic and needs an astute
clinical sense with a high index of clinical suspicion to capture
it early enough for an effective and complete cure [13]. The
disease manifestation depends on the status of the host T cell
immunity. The T cell immunity per se is protective. If the
person contracts infection with a strong T cell immune re-
sponse, the bacillary growth is restricted, but the resultant
nerve damage may be profound, as seen in tuberculoid lepro-
sy. In contrast, a widespread dissemination of mycobacterium
takes place if the T cell immune response is low, resulting in
the lepromatous spectrum of disease. Borderline disease sub-
sets have intermediate T cell immune response.
Patients with leprosy can present with dominant rheumatic
manifestations as shown in the current report. More uncom-
monly, this presentation may be an acute inflammatory
polyarthritis mimicking RA: two males with borderline lepro-
matous leprosy presented with type I reaction in our rheuma-
tology outpatient [13]. We did not find tenosynovitis in
isolation though leprosy has been uncommonly diagnosed in
a patient with tenosynovitis (in the absence of arthritis) with
thickened nerves [14]. Leprosy can also mimic several forms
of collagen vascular disease, including systemic lupus ery-
thematous and scleroderma, due to its predominant skin af-
fection, but the clinical profile of digital gangrene due to
arteritis in case 1 in the current report is rather unusual.
Cossermelli-Messina et al. [15] described 39 cases of lep-
rosy with chronic RA-like arthritis (mean duration 11 years);
leprosy-related reactions were not reported. Leprosy was pres-
ent for >10 years in most of their patients and was currently
inactive in 19 of them. Although these patients had consider-
able relief with anti-leprosy therapy, the arthritis never re-
solved completely and was likely to have been complicated
by neuropathic features. Surprisingly, though we did see some
patients with chronic leprosy, none of the patients had neuro-
pathic destructive arthritis, and this is likely to be due to early
diagnosis and appropriate anti-leprosy treatment. In the cur-
rent report, 22, 9, and 2 patients, respectively, were classified
as LL, TT, and neuritic according to the Ridley–Jopling clas-
sification scale [16]; intermediate form was not seen. In sev-
eral patients, polyarthritis was similar to RA, but we did not
find erosive arthritis on radiological examination. The flexion
contractures were generally subtle except in two patients with
distinct claw hand who were mislabeled as having rheumatoid
hand with Boutonniere’s deformity; a closer look revealed
typical neurologic abnormality. We did not find a foot drop
which is often encountered in leprosy. Seventeen patients in
our series had sensory system involvement, and three had feet
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digital trophic ulcers; NCV study was carried out in five
patients and showed sensory motor peripheral neuropathy of
axonal type. Painless thickened ulnar nerve (near the elbow)
and peroneal nerve (below the knee) were often found in our
patients. Peripheral nerve involvement is usually more and
appears earlier in TT than in LL [17]. Though RA can be
complicated by peripheral neuropathy, and uncommonly, a
claw hand seen as a manifestation of ulnar nerve affection,
leprosy must be meticulously excluded in our setting.
Rheumatoid vasculitis may involve virtually any organ of
the body including the skin and nervous system [18].
Tuberculosis is an important complication of prolonged
steroid and immunosuppressive therapy in our community
[19], but leprosy should also be kept in mind as was
highlighted by case no. 2 of this report. Patients with in-
flammatory rheumatic disorders often receive chronic im-
munosuppressive therapy and biologic agents (anti-TNF)
[20], and this makes them prone to several opportunistic
and community infections. In another rare parallel, leprosy
was reported in patients with HIV infection on antiretroviral
therapy, as a manifestation of immune reconstitution inflam-
matory syndrome [5, 21].
Several autoantibodies like RF and ANAwhich are com-
monly tested in rheumatological disorders may be false
positive in leprosy [22]. In the current report, we report
similar false seropositivity. Interestingly, none of the pa-
tients tested in the current series were seropositive for anti-
CCP, which has a higher diagnostic value in RA [23].
The author (AC) completed population surveys of over
12,000 population in urban Pune and rural Bhigwan (Pune
district) under the auspices of the WHO International
League of Associations for Rheumatology Community-
Oriented Program for Control of Rheumatic Diseases and
reported a wide spectrum of rheumatic pain and disorders
[24]. About 10 % of the community patients suffered from
inflammatory arthritis, but none was found to suffer from
leprosy or tuberculosis-associated arthritis. One woman pa-
tient of RA slowly developed claw hand and other features
of tuberculoid leprosy during the 10-year follow-up in the
Bhigwan community (unpublished).
Though uncommon, leprosy can present in rheumatology
outpatient as was shown by the current study. Rheumatologists
ought to be aware of this important differential diagnosis. It is
also prudent to recommend a close interaction with a derma-
tologist in such situations where the excellent response to anti-
lepromatous drugs can save patients from needless antirheu-
matic therapy.
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